Close Menu

CHICAGO (GenomeWeb) – Molecular tumor boards are continuing to gain treatment clues from individuals' cancer sequences, at the same time as growing cancer data collections reveal broader tumor features across patients.

At the American Association for Cancer Research annual meeting here yesterday, Arul Chinnaiyan reported on some of the results coming out of the University of Michigan's "Michigan Oncology Sequencing Center" (MiOncoSeq) research program, which has sequenced matched tumor and normal samples and generated tumor transcriptomes for roughly 3,000 cancer patients so far.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Jul
23
Sponsored by
Qiagen: Nov 16, 2014

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul
31
Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.

Aug
28
Sponsored by
Horizon Discovery

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.